IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
0.8205
+0.0045 (0.55%)
Nov 17, 2026, 9:38 AM EST - Market open

IN8bio Statistics

Total Valuation

IN8bio has a market cap or net worth of $8.87 million. The enterprise value is -$2.35 million.

Market Cap8.87M
Enterprise Value -2.35M

Important Dates

The last earnings date was Thursday, November 5, 2026, after market close.

Earnings Date Nov 5, 2026
Ex-Dividend Date n/a

Share Statistics

IN8bio has 10.81 million shares outstanding. The number of shares has increased by 404.34% in one year.

Current Share Class 10.81M
Shares Outstanding 10.81M
Shares Change (YoY) +404.34%
Shares Change (QoQ) +0.03%
Owned by Insiders (%) 2.89%
Owned by Institutions (%) 17.78%
Float 8.13M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.57
P/TBV Ratio 0.62
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.78, with a Debt / Equity ratio of 0.19.

Current Ratio 5.78
Quick Ratio 5.32
Debt / Equity 0.19
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -141.83% and return on invested capital (ROIC) is -75.43%.

Return on Equity (ROE) -141.83%
Return on Assets (ROA) -70.34%
Return on Invested Capital (ROIC) -75.43%
Return on Capital Employed (ROCE) -124.20%
Weighted Average Cost of Capital (WACC) 4.27%
Revenue Per Employee n/a
Profits Per Employee -$970,250
Employee Count20
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -48.68% in the last 52 weeks. The beta is 0.24, so IN8bio's price volatility has been lower than the market average.

Beta (5Y) 0.24
52-Week Price Change -48.68%
50-Day Moving Average 1.10
200-Day Moving Average 1.38
Relative Strength Index (RSI) 34.69
Average Volume (20 Days) 287,571

Short Selling Information

The latest short interest is 15,733, so 0.15% of the outstanding shares have been sold short.

Short Interest 15,733
Short Previous Month 32,797
Short % of Shares Out 0.15%
Short % of Float 0.19%
Short Ratio (days to cover) 0.38

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -19.96M
Pretax Income -19.41M
Net Income -19.41M
EBITDA -18.60M
EBIT -19.96M
Earnings Per Share (EPS) -$1.18
Full Income Statement

Balance Sheet

The company has $13.97 million in cash and $2.75 million in debt, with a net cash position of $11.22 million or $1.04 per share.

Cash & Cash Equivalents 13.97M
Total Debt 2.75M
Net Cash 11.22M
Net Cash Per Share $1.04
Equity (Book Value) 14.17M
Book Value Per Share 1.44
Working Capital 12.57M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.76 million and capital expenditures -$241,000, giving a free cash flow of -$15.00 million.

Operating Cash Flow -14.76M
Capital Expenditures -241,000
Depreciation & Amortization 1.35M
Net Borrowing -342,000
Free Cash Flow -15.00M
FCF Per Share -$1.39
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

IN8bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -404.34%
Shareholder Yield -404.34%
Earnings Yield -144.39%
FCF Yield -170.07%

Analyst Forecast

The average price target for IN8bio is $7.00, which is 753.14% higher than the current price. The consensus rating is "Strong Buy".

Price Target $7.00
Price Target Difference 753.14%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on June 6, 2025. It was a reverse split with a ratio of 1:30.

Last Split Date Jun 6, 2025
Split Type Reverse
Split Ratio 1:30

Scores

Altman Z-Score n/a
Piotroski F-Score 1